Back to top

Image: Bigstock

Avient (AVNT) Q4 Earnings and Revenues Surpass Estimates

Read MoreHide Full Article

Avient (AVNT - Free Report) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.39 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of 10.64%. A quarter ago, it was expected that this maker of resins used in plastic pipe and other products would post earnings of $0.57 per share when it actually produced earnings of $0.57, delivering no surprise.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Avient, which belongs to the Zacks Chemical - Diversified industry, posted revenues of $719 million for the quarter ended December 2023, surpassing the Zacks Consensus Estimate by 1.36%. This compares to year-ago revenues of $790.4 million. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Avient shares have lost about 13.2% since the beginning of the year versus the S&P 500's gain of 3.8%.

What's Next for Avient?

While Avient has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Avient: unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.60 on $788.87 million in revenues for the coming quarter and $2.53 on $3.18 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Diversified is currently in the bottom 8% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, Stepan Co. (SCL - Free Report) , is yet to report results for the quarter ended December 2023. The results are expected to be released on February 20.

This specialty chemicals company is expected to post quarterly earnings of $0.37 per share in its upcoming report, which represents a year-over-year change of -37.3%. The consensus EPS estimate for the quarter has been revised 3.4% lower over the last 30 days to the current level.

Stepan Co.'s revenues are expected to be $534.53 million, down 14.8% from the year-ago quarter.

See More Zacks Research for These Tickers

Normally $25 each - click below to receive one report FREE:

Stepan Company (SCL) - free report >>

Avient Corporation (AVNT) - free report >>

Published in